14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Apr 19, 2018 $14.40 $14.45 $14.03 $14.20 1 300 757
Apr 18, 2018 $14.55 $14.90 $14.15 $14.50 1 205 802
Apr 17, 2018 $14.60 $14.73 $14.20 $14.55 868 844
Apr 16, 2018 $14.80 $14.80 $14.13 $14.55 882 063
Apr 13, 2018 $14.50 $14.80 $14.20 $14.70 746 914
Apr 12, 2018 $14.15 $14.55 $13.65 $14.35 1 135 116
Apr 11, 2018 $13.20 $14.35 $13.00 $14.15 1 545 514
Apr 10, 2018 $12.75 $13.25 $12.55 $13.20 973 179
Apr 09, 2018 $12.70 $12.85 $12.55 $12.65 683 493
Apr 06, 2018 $12.70 $13.15 $12.35 $12.60 967 729
Apr 05, 2018 $12.80 $12.95 $12.45 $12.85 1 114 867
Apr 04, 2018 $12.45 $12.95 $12.44 $12.70 1 086 163
Apr 03, 2018 $12.65 $12.90 $12.40 $12.65 1 142 320
Apr 02, 2018 $12.60 $12.85 $12.20 $12.55 1 353 269
Mar 29, 2018 $12.15 $12.90 $11.95 $12.70 1 417 766
Mar 28, 2018 $11.65 $12.15 $11.20 $12.10 1 393 951
Mar 27, 2018 $11.95 $12.20 $11.35 $11.50 1 457 798
Mar 26, 2018 $11.50 $12.25 $11.50 $11.95 2 089 005
Mar 23, 2018 $11.30 $11.75 $11.15 $11.25 1 630 631
Mar 22, 2018 $11.55 $11.60 $10.90 $11.35 3 083 038
Mar 21, 2018 $13.20 $13.23 $11.15 $11.55 5 819 997
Mar 20, 2018 $13.80 $14.10 $13.55 $13.60 510 113
Mar 19, 2018 $14.00 $14.15 $13.85 $13.90 849 464
Mar 16, 2018 $14.10 $14.48 $14.00 $14.15 1 445 516
Mar 15, 2018 $14.60 $14.75 $13.98 $14.05 960 612
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT